Open AccessS1013 Lack of Colonic Microbial Cross-Resistance to Other Antibiotics in Patients Treated With Rifaximin Alone vs Rifaximin Plus Lactulose for Reducing the Risk of Overt Hepatic Encephalopathy (OHE) Recurrence
Author(s) -
Catherine Frenette,
Vinay Sundaram,
Zeev Heimanson,
Robert Israel,
Arun J. Sanyal
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000706100.58826.f6
Subject(s) - rifaximin , lactulose , medicine , gastroenterology , antibiotics , hepatic encephalopathy , cirrhosis , microbiology and biotechnology , biology